Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q4 2016 · 10-K
Revenue$242.34M$242.34M+7.0% vs Q4 2015 Net Income-$8.74M-$8.74MN/M vs Q4 2015 EPS Diluted-$0.17-$0.17N/M vs Q4 2015 Gross Profit$89,223,000−17.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flowderived$53,253,000−3.7% Free Cash Flowderived$24,719,000−26.5% Margins · derivedGross margin36.8%−11.0 pt vs Q4 2015
Operating margin-2.3%−7.4 pt vs Q4 2015
Net margin-3.6%−2.3 pt vs Q4 2015
ended Apr 2, 2016 · filed Jun 1, 2016 · 60 d after period end